Suven Life Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

SUVEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.9%1-day move

₹167.55

prior close

₹165.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+2.9+2.6+3.1+2.2+0.9+6.0+17.6+13.4+14.6+16.4+29.4+31.6+39.1+89.5

Up moveDown movePending

AI summary

Suven Life Sciences has submitted a regulatory certificate to BSE and NSE confirming compliance with SEBI Regulation 74(5). The certificate, dated April 1, 2026, was issued by Kfin Technologies Limited—the company's Registrar and Share Transfer Agent (RTA). It confirms that details of securities dematerialized and rematerialized during Q4 FY2026 (January-March 2026) have been properly furnished to both depositories—CDSL and NSDL—and to all relevant stock exchanges. This is a standard quarterly compliance filing required under SEBI regulations for all listed companies. No issues or discrepancies were flagged in the filing.

Likely market impact

This is a routine regulatory filing with no direct impact on the stock price or shareholder value. It simply confirms that share dematerialization records were submitted on time to depositories, indicating normal operational status of the company's share registry.